1 – 10 of 22
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
- Effect of dolutegravir in combination with Nucleoside Reverse Transcriptase Inhibitors (NRTIs) on people living with HIV who have pre-existing NRTI mutations
- Increase in transmitted drug resistance in migrants from sub-Saharan Africa diagnosed with HIV-1 in Sweden
- 2017
- Virological failure and all-cause mortality in HIV-positive adults with low-level viremia during antiretroviral treatment
- Effect of therapy switch on time to second-line antiretroviral treatment failure in HIV-infected patients
- Ex vivo 18O-labeling mass spectrometry identifies a peripheral amyloid β clearance pathway
- 2016
- Viral blips during suppressive antiretroviral treatment are associated with high baseline HIV-1 RNA levels
- Reduced baseline sensitivity to Maraviroc inhibition among R5 HIV-1 isolates from individuals with severe immunodeficiency.
- 2015
- Six-week follow-up after HIV-1 exposure: a position statement from the Public Health Agency of Sweden and the Swedish Reference Group for Antiviral Therapy.
- 2014
- Prophylaxis and treatment of HIV-1 infection in pregnancy: Swedish recommendations 2013
- Risk of HIV transmission from patients on antiretroviral therapy: A position statement from the Public Health Agency of Sweden and the Swedish Reference Group for Antiviral Therapy